Overnight Remote Authorization Jobs (NOW HIRING)

The Neurology Account Director is a field-based institutional key account role responsible for driving the launch and ongoing commercial performance of Regeneron's C5 inhibitor for generalized myasthenia gravis (gMG) within approximately 10 - 12 assigned academic medical centers (AMCs) infusion centers, and neuromuscular specialty centers. The account director serves as a Regeneron commercial point of contact within targeted institutions, responsible for formulary access, infusion suite education and pull-through, and long-term institutional partnership development. The AD combines deep MG clinical acumen, institutional navigation skills, financial acumen, and cross-functional coordination to maximize patient access and revenue within their assigned territory.

When & where:

• Remote role
• Location: Mountain West (Minnesota, Iowa, Missouri, Kansas, Idaho, Colorado, New Mexico and Arizona)
• Travel: Up to 60–70%, including overnight travel within assigned territory

Discover your role:

Institutional Account Management

• Own and manage a portfolio of approximately 10 -12 AMCs and neuromuscular specialty centers within an assigned U.S. region, serving as the institutional commercial lead.
• Develop and execute comprehensive account plans for each institution, including formulary strategy, stakeholder mapping, competitive positioning, and patient access pathways.
• Navigate complex institutional buying environments including P&T committees, pharmacy contracting, hospital administration, and infusion center operations.
• Build and maintain deep, trust-based relationships with neurology department heads, treating neurologists, clinical pharmacists, infusion nurses, and medical directors.

Formulary & Market Access Pull-Through

• Lead formulary and pathway submissions and P&T committee presentations at targeted institutions, positioning the C5 inhibitor for preferred or unrestricted formulary status.
• Partner with Market Access National and Payer Account Directors to align institutional contracting with broader payer strategy and resolve prior authorization barriers.
• Coordinate with specialty pharmacy partners and Patient Services hub to ensure seamless reimbursement workflows for buy-and-bill infusion products.
• Track formulary status, pull-through metrics, and access barriers across all assigned accounts; escalate systemic issues with data-driven recommendations.

Stakeholder & KOL Engagement

• Identify, develop, and maintain relationships with key opinion leaders (KOLs) in neuromuscular medicine within assigned territory, in coordination with Medical Affairs.
• Represent Regeneron at national and regional neurology congresses (AAN, MGFA), medical education events, and institutional grand rounds as appropriate.

Analytics, Planning & Reporting

• Maintain detailed CRM records and account intelligence; leverage IQVIA/Symphony Health data for prescriber-level targeting and performance measurement.
• Track and report on KPIs including accounts engaged, formulary inclusions achieved, patient switches, revenue per account, and competitive share of voice.
• Prepare and present quarterly business reviews to the Executive Director, highlighting account progress, barriers, competitive dynamics, and resource needs.
• Contribute to territory realignment recommendations and Year 2 expansion planning based on field-level market intelligence.

This role requires:

• Bachelor's degree required; PharmD, RN, or advanced degree in life sciences strongly preferred.
• Minimum 10-12+ years institutional sales, market access, or account management experience in pharmaceutical/biotech.
• Demonstrated experience with hospital/AMC formulary processes, P&T committee engagement, and institutional buy-and-bill contracting.
• Track record of success in rare disease, neurology, or specialty biologic sales/account management, ideally including launch experience.
• Strong clinical acumen with the ability to engage physicians, pharmacists, and medical directors in scientifically rigorous conversations.
• Experience executing competitive switch or conversion strategies in institutional settings.
• Proficiency with CRM systems and commercial analytics platforms (IQVIA, Symphony Health, specialty pharmacy data).
• Ability to manage complex, multi-stakeholder account relationships independently with minimal supervision.
• Willingness to travel 60–70% within assigned territory, including overnight travel.
• Candidates must reside within the assigned territory.

Preferred:

• Experience in complement biology, neuromuscular disease, or C5/FcRn inhibitor markets.
• Existing relationships with neurology KOLs or MGFA-recognized center-of-excellence leadership.
• Prior experience with infusion biologic launches in hospital/outpatient infusion settings.
• Knowledge of specialty pharmacy hub operations, patient assistance programs, and prior authorization workflows.
• Understanding of medical benefit (Part B) reimbursement, ASP pricing dynamics, and buy-and-bill economics.

Core Competencies:

• Clinical Credibility – Translates C5 mechanism of action, dosing differentiation, and clinical evidence into compelling value propositions that resonate with treating physicians and institutional decision-makers.
• Institutional Account Navigation – Expertly engages across all levels of AMC hierarchies, from neurology fellows to C-suite administrators, pharmacy directors to infusion center leadership.
• Strategic Account Planning – Builds data-driven, multi-quarter account strategies that address formulary access, competitive positioning, and patient journey barriers.
• Patient Journey Management – Coordinates cross-functionally with Patient Services, specialty pharmacy, and market access to remove barriers and ensure seamless treatment initiation and continuation.
• Relationship Building – Develops deep, trust-based institutional partnerships that create long-term competitive advantages in rare neuromuscular disease.
• Results Orientation – Drives measurable outcomes through disciplined account planning, KPI tracking, and relentless follow-through on formulary wins.